Fananserin

法南色林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFananserin
Drug Alias NameRP-62203
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsDopamine D4 receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D4 receptor
Therapy Area/IndicationsSchizophreniaDepressive Disorder, MajorAnxiety
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsSchizophreniaDepressive Disorder, MajorAnxiety

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG